SonoThera Closes Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Ultrasound-Mediated ...

Autosomal dominant polycystic kidney disease (ADPKD) causes cysts to grow in your kidneys. It's one of the most common genetic kidney diseases. ADPKD is inherited. It's caused by a change, or mutation ...

Add Yahoo as a preferred source to see more of our stories on Google. Sep. 3—(StatePoint) This article is sponsored by Otsuka America Pharmaceutical, Inc. Each year, September 4 marks Polycystic ...

Mayo Clinic's Vascular Biology and Biomarker Discovery in Polycystic Kidney Disease Lab leads studies to identify early ...

Major complications occur in 7.0% of patients undergoing nephrectomy with a diagnosis of autosomal dominant polycystic kidney disease (ADPKD), according to a study published online Dec. 17 in Urology ...

The Kidney Disease: Improving Global Outcomes (KDIGO) group has released its 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney ...

In a real-world study of patients with ADPKD, tolvaptan treatment decreased long-term kidney function decline but did not slow kidney growth. Tolvaptan eases long-term kidney function decline in ...

Developing new gene therapies for autosomal dominant polycystic kidney disease (ADPKD) is still a challenge to date. A group of researchers from the Johns Hopkins Medicine in Baltimore has presented ...

Pregnancy does not appear to affect autosomal dominant polycystic kidney disease progression, according to study data ...

Clinicians managing patients with ADPKD should have high clinical suspicion for post-transplant diabetes, infection, and thromboembolism. Patients with autosomal dominant polycystic kidney disease ...

Three cohort studies, including nearly 7900 patients with ADPKD, were among the 18 studies included in the final analysis. Individuals diagnosed with ADPKD had a higher rate of cardiovascular events ...